Literature DB >> 7733875

Glycosphingolipid composition of rat placenta: changes associated with stage of pregnancy.

S Itonori1, T Shirai, Y Kiso, Y Ohashi, K Shiota, T Ogawa.   

Abstract

The composition of glycolipids and their changes in the placenta were investigated in the normal pregnant rat. Total lipid fractions extracted from the placenta between days 12 and 20 of pregnancy (day 0 = oestrus) were subjected to glycolipid analysis using DEAE-Sephadex chromatography, silica-gel HPLC, silica-gel TLC, TLC/immunostaining, matrix-assisted secondary-ion mass spectrometry in the negative-ion mode and 1H NMR. Glycolipids identified in the rat placenta were: gangliosides GM3 (NeuAcLacCer and NeuGcLacCer) and GD3 (NeuAcNeuAcLacCer, NeuAcNeuGcLacCer and NeuGcNeuAcLacCer), and neutral glycolipids ceramide monosaccharide (CMH) (GlcCer), ceramide disaccharide (CDH) (LacCer), ceramide trisaccharide (CTH) (Gb3Cer) and ceramide tetrasaccharide (CQH) (Gb4Cer). The content of neutral glycolipids was higher than that of gangliosides throughout pregnancy. Of the neutral glycolipids, CMH and CTH predominated and the level of CDH was low at mid-pregnancy. During late pregnancy, CMH and CTH decreased and CDH increased markedly. CQH remained at a low level throughout pregnancy. Of the gangliosides, GM3 was predominant on days 12-16 and then decreased, whereas GD3, which was low on day 12, increased slightly on day 16 and maintained the same level thereafter. Immunohistochemical studies indicated that these changes in the expression of major gangliosides from GM3 to GD3 occurred in labyrinthine trophoblasts. Thus expression of these glycolipids appears to change markedly during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733875      PMCID: PMC1136662          DOI: 10.1042/bj3070399

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Monoclonal antibody R24 distinguishes between different N-acetyl- and N-glycolylneuraminic acid derivatives of ganglioside GD3.

Authors:  T Tai; I Kawashima; K Furukawa; K O Lloyd
Journal:  Arch Biochem Biophys       Date:  1988-01       Impact factor: 4.013

2.  Antibodies to cell surface ganglioside GD3 perturb inductive epithelial-mesenchymal interactions.

Authors:  H Sariola; E Aufderheide; H Bernhard; S Henke-Fahle; W Dippold; P Ekblom
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

3.  The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group Pk1 woman and analysis of the anti-globoside antibodies found in maternal serum.

Authors:  G C Hansson; K Wazniowska; J A Rock; P M Ness; T S Kickler; R S Shirey; J R Niebyl; D Zopf
Journal:  Arch Biochem Biophys       Date:  1988-01       Impact factor: 4.013

4.  Novel tri-and tetrasialosylpoly-N-acetyllactosaminyl gangliosides of human placenta: structure determination of pentadeca- and eicosaglycosylceramides by methylation analysis, fast atom bombardment mass spectrometry, and 1H NMR spectroscopy.

Authors:  S B Levery; E D Nudelman; M E Salyan; S Hakomori
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

5.  Human placenta gangliosides.

Authors:  T Taki; K Matsuo; K Yamamoto; T Matsubara; A Hayashi; T Abe; M Matsumoto
Journal:  Lipids       Date:  1988-03       Impact factor: 1.880

6.  Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

Authors:  R K Yu; L J Macala; T Taki; H M Weinfield; F S Yu
Journal:  J Neurochem       Date:  1988-06       Impact factor: 5.372

7.  A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth.

Authors:  N Hanai; T Dohi; G A Nores; S Hakomori
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

Review 8.  Functions of sphingolipids and sphingolipid breakdown products in cellular regulation.

Authors:  Y A Hannun; R M Bell
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

9.  Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.

Authors:  A N Houghton; D Mintzer; C Cordon-Cardo; S Welt; B Fliegel; S Vadhan; E Carswell; M R Melamed; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

10.  Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.

Authors:  D A Cheresh; M D Pierschbacher; M A Herzig; K Mujoo
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

View more
  2 in total

Review 1.  NKT cells at the maternal-fetal interface.

Authors:  J E Boyson; I Aktan; D A Barkhuff; A Chant
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

2.  Ganglioside composition of the rat choriocarcinoma cell line, Rcho-1.

Authors:  T Shirai; S Itonori; T Tai; M J Soares; K Shiota; T Ogawa
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.